Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001286925 | SCV001473554 | uncertain significance | Polycystic kidney disease, adult type | 2020-02-26 | criteria provided, single submitter | clinical testing | The PKD1 c.9694A>G; p.Lys3232Glu variant is reported in the literature in at least one individual affected with autosomal dominant polycystic kidney disease who carried another PKD1 variant (Rossetti 2012). The p.Lys3232Glu variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The lysine at codon 3232 is highly conserved, and computational analyses (SIFT: tolerated, PolyPhen-2: possibly damaging) predict conflicting effects of this variant on protein structure/function. Due to limited information, the clinical significance of the p.Lys3232Glu variant is uncertain at this time. References: Rossetti S et al. Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing. J Am Soc Nephrol. 2012 May;23(5):915-33. |